Cerebral MR perfusion imaging: First clinical application of a 1 M gadolinium chelate (Gadovist 1.0) in a Double-blinded randomized dose-finding study

Journal of Magnetic Resonance Imaging

Volumn 12, Issue 3, 2000, Pages 371-380

  Benner, Thomas ^a   Reimer, Peter ^b   Erb, Gunter ^a   Schuierer, Gerhard ^b   Heiland, Sabine ^a   Fischer, Carsten ^b   Geens, Viviane ^c   Sartor, Klaus ^a   Forsting, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c BAYER PHARMA AG   (Germany)

Author keywords

Cerebral perfusion; Gadolinium chelate; Magnetic resonance imaging; Paramagnetic contrast media

Indexed keywords

CONTRAST MEDIUM; GADOBUTROL; GADODIAMIDE; GADOLINIUM CHELATE; GADOLINIUM PENTETATE; GADOTERIDOL;

ADULT; AGED; ARTICLE; BRAIN BLOOD VOLUME; BRAIN PERFUSION; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIGNAL NOISE RATIO; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN; CAROTID STENOSIS; CEREBRAL INFARCTION; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PERFUSION; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 0033846018     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/1522-2586(200009)12:3<371::AID-JMRI1>3.0.CO;2-3     Document Type: Article

References (45)

1. Cerebral infarction: Assessment of patterns using ultra-fast MR contrast imaging
2. Acute cerebral ischemia: Evaluation with dynamic contrast-enhanced MR imaging and MR angiography
3. Measurement of cerebrovascular changes in cats after transient ischemia using dynamic magnetic resonance imaging
4. Echo-planar perfusion-sensitive MR imaging of acute cerebral ischemia
5. Contrast-enhanced perfusion-sensitive MR imaging in the diagnosis of cerebrovascular disorders
6. Acute stroke in cats: Comparison of dynamic susceptibility-contrast MR imaging with T2- and diffusion-weighted MR imaging
7. Tumor vascularity in the brain: Evaluation with dynamic susceptibility-contrast MR imaging
8. Cerebral blood volume maps of gliomas: Comparison with tumor grade and histologic findings
9. Assessment of cerebral blood volume with dynamic susceptibility contrast enhanced gradient-echo imaging
10. Vascularity of meningiomas and neuromas: Assessment with dynamic susceptibility-contrast MR imaging
11. Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting
12. Susceptibility contrast imaging of cerebral blood volume: Human experience
13. Cerebral hemodynamics and cerebral blood volume: MR assessment using gadolinium contrast agents and T1-weighted Turbo-FLASH imaging
14. Quantification of regional blood volumes by rapid T1 mapping
15. In vivo regional cerebral blood volume: Quantitative assessment with 3D T1-weighted pre- and postcontrast MR imaging
16. Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects
17. Functional cerebral imaging by susceptibility-contrast NMR
18. Cerebral blood flow: Assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T
19. Susceptibility changes following bolus injections
20. Functional brain MR imaging based on bolus tracking with a fast T2*-sensitized gradient-echo method
21. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging
22. Cerebrovascular transit characteristics of DyDTPA-BMA and GdDTPA-BMA on normal and ischemic cat brain
23. Assessment of cerebral perfusion by first-pass, dynamic, contrast-enhanced, steady-state free-precession MR imaging: An animal study
24. MR contrast due to intravascular magnetic susceptibility perturbations
25. Accuracy of gamma-variate fits to concentration-time curves from dynamic susceptibility-contrast enhanced MRI: Influence of time resolution, maximal signal drop and signal-to-noise
26. Contrast-to-noise ratio in functional MRI of relative cerebral blood volume with sprodiamide injection
27. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: Which mean transit time?
28. Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers
29. Diagnosis of cerebral metastasis with standard dose gadobutrol vs. a high dose protocol. Intraindividual evaluation of a phase II high dose study
30. Does the administration of a high dose of a paramagnetic contrast medium (Gadovist) improve the diagnostic value of magnetic resonance tomography in glioblastomas?
31. Pre-clinical evaluation of gadobutrol: A new, neutral, extracellular contrast agent for magnetic resonance imaging
32. Dynamic contrast-enhanced MR imaging of the upper abdomen: Enhancement properties of gadobutrol, gadolinium-DTPA-polylysine, and gadolinium-DTPA-cascade-polymer
33. Evaluation of gadobutrol in a rabbit model as a new lanthanide contrast agent for computed tomography
34. Spoiling of transverse magnetization in gradient-echo (GRE) imaging during the approach to steady state
35. On the stationary states in gradient echo imaging
36. In vitro evaluation of a mechanical injector for infusion of magnetic resonance contrast media
37. Indicator transit time considered as a gamma variate
38. The derivation of the gamma-variate relationship for tracer dilution curves
39. A method for the solution of certain problems in least squares
40. An algorithm for least squares estimation of non-linear parameters
41. On the theory of the indicator-dilution method for measurement of blood flow and volume
42. Cerebral blood flow determination by rapid-sequence computed tomography: Theoretical analysis
43. A general overview of Mantel-Haenszel methods: Applications and recent developments
44. Effect of field strength on susceptibility artifacts in magnetic resonance imaging
45. Intravascular susceptibility contrast mechanisms in tissues